Managing pre-eclampsia and eclampsia in Dar es Salaam public health facilities: A focus on equipment, supplies, drugs and knowledge of healthcare workers
DOI:
https://doi.org/10.4314/tmj.v27i1.192Keywords:
Pre-eclampsia, Eclampsia, Equipment and supplies, Drugs, KnowledgeAbstract
IntroductionSevere pre-eclampsia and eclampsia (PE/E) is associated with high maternal and neonatal morbidity and mortality. Early detection and treatment of pre-eclampsia may prevent progression to severe PE/E. When severe PE/E occurs, timely use of anticonvulsants and antihypertensives (as part of emergency obstetric and neonatal care) are needed to reduce morbidity and mortality. This study is aimed at assessing the capacity in managing PE/E in public health facilities in Dar-es-Salaam, Tanzania.
MethodsA descriptive cross-sectional study was conducted in selected public health facilities in Dar-es-Salaam city that offer reproductive and child services. The health facilities included four hospitals, three health centres and 23 dispensaries. A checklist was used to assess availability of equipment, supplies and drugs, and a structured questionnaire administered by an interviewer was used to assess healthcare workers’ knowledge on risks, symptoms, and drugs used to manage for PE/E. The results are presented as proportions.
ResultsGuidelines for management of PE/E were available in all hospitals and health centres while 39% of the dispensaries had no the guidelines. Functioning blood pressure machines and stethoscopes were available in all facilities but urine test strips for detecting protein in the urine were available in only one hospital (25%) and 9 (39%) dispensaries. Anticonvulsant drugs were available in all health facilities. Magnesium sulphate, the first-line recommended anticonvulsant, was available in only a quarter of the dispensaries. A quarter of the dispensaries had nifedipine or methyldopa available as antihypertensives, with availability for both drugs being 75% and 100% in the hospitals and health centres respectively. The antihypertensive hydralazine was available in 50%, 33% and 8% of the hospitals, health centres and dispensaries respectively. Calcium gluconate was available in one hospital and one health centre only.
Healthcare workers were knowledgeable regarding most risk factors, symptoms and drugs for treatment of hypertension and convulsions in PE/E. A higher proportion of doctors were knowledgeable of the risk factors, symptoms and drugs than the nurses and clinical officers. The majority of the healthcare workers mentioned magnesium sulphate as the drug for treatment of convulsions in PE/E.
ConclusionsThere is insufficient screening and management of PE/E due to lack of equipment, supplies and drugs. Healthcare workers are relatively knowledgeable regarding risk factors, symptoms and drugs for managing PE/E. This calls for an increase in availability of equipment, supplies and drugs for managing women with PE/E. Healthcare workers need to receive ongoing education to sustain quality care for women with PE/E.
References
Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull. 2003;67:161-176.
Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. Nov 10 2007;335(7627):974.
Conde-Agudelo A, Belizan JM. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG. Jan 2000;107(1):75-83.
Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. Mar 12 2005;330(7491):565.
Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. Jun 2009;33(3):130-137.
WHO. The World Health Report 2005: Make every mother and child count. Geneva: World Health Organization; 2005.
Urassa DP, Carlstedt A, Nystrom L, Massawe SN, Lindmark G. Eclampsia in Dar es Salaam, Tanzania -- incidence, outcome, and the role of antenatal care. Acta Obstet Gynecol Scand. 2006;85(5):571-578.
Urassa E, Lindmark G, Nystrom L. Maternal mortality in Dar es Salaam, Tanzania: Socio-economic, obstetric history and accessibility of health care factors. Afr J Health Sci. Feb 1995;2(1):242-249.
Kazaura MR, Kidanto HL, Massawe SN. Maternal mortality at Muhimbili National Hospital,Tanzania,1999-2005:levels,causes and characteristics. East African Journal of Public Health. 2006;3(2):23-25.
Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension. Jul 2003;42(1):39-42.
Kidanto HL, Mogren I, Massawe SN, Lindmark G, Nystrom L. Criteria-based audit on management of eclampsia patients at a tertiary hospital in Dar es Salaam, Tanzania. BMC Pregnancy Childbirth. 2009;9:13.
Ndaboine EM, Kihunrwa A, Rumanyika R, Im HB, Massinde AN. Maternal and perinatal outcomes among eclamptic patients admitted to Bugando Medical Centre, Mwanza, Tanzania. Afr J Reprod Health. Mar 2012;16(1):35-41.
Boller C, Wyss K, Mtasiwa D, Tanner M. Quality and comparison of antenatal care in public and private providers in the United Republic of Tanzania. Bull World Health Organ. 2003;81(2):116-122.
Urassa DP, Nystrom L, Carlstedt A, Msamanga GI, Lindmark G. Management of hypertension in pregnancy as a quality indicator of antenatal care in rural Tanzania. Afr J Reprod Health. Dec 2003;7(3):69-76.
NBS. Tanzania Service Provision Assessment Survey 2006. Dar es Salaam, Tanzania: National Bureau of Statistics (NBS) and ORC Macro; 2007.
Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010(11):CD000025.
Ekele BA. Use of magnesium sulfate to manage pre-eclampsia and eclampsia in Nigeria: overcoming the odds. Ann Afr Med. Apr-Jun 2009;8(2):73-75.
MoHSW. Focused antenatal care, malaria and syphylis in pregnancy: Orientation package for service providers. Dar es Salaam: Ministry of Health and Social welfare, The United Republic of Tanzania; 2002.
MoHSW. Emergency Obstetric Job Aid. Guidelines for Tanzania. Dar es Salaam, Tanzania: Ministry of Health and Social Welfare (MoHSW); 2008.
Kielmann A, Janovsky K, Annett K. Protocol for rapid data collection and analysis. Assessing District Health Needs, Services and Systems. London: Macmillan Education LTD; 1995.
UNICEF, UNFPA, WHO. Guidelines for Monitoring the Availability and Use of Obstetric Services. New York: UNICEF; 1997.
Penfold S, Shamba D, Hanson C, et al. Staff experiences of providing maternity services in rural southern Tanzania - a focus on equipment, drug and supply issues. BMC Health Serv Res. 2013;13:61.
Lumbiganon P, Gulmezoglu AM, Piaggio G, Langer A, Grimshaw J. Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be. Bull World Health Organ. Oct 2007;85(10):763-767.
MoHSW. Standard Treatment Guidelines Tanzania Mainland. Dar es Salaam, Tanzania: Ministry of Health and Social Welfare (MoHSW); 2007.
Okonofua FE, Ogu RN, Fabamwo AO, et al. Training health workers for magnesium sulfate use reduces case fatality from eclampsia: results from a multicenter trial. Acta Obstet Gynecol Scand. Jun 2013;92(6):716-720.